These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9009675)

  • 1. The effect of a pulsed magnetic field and that of methyl-silane triol on galactosamine induced hepatitis among rats.
    Bellossi A; Nawrocki T; Pouvreau-Quillien V; Arulmozhi V; Rocher C; Ruelloux M
    Panminerva Med; 1996 Sep; 38(3):133-8. PubMed ID: 9009675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug-induced hepatotoxicity by plasma retinol binding protein.
    Isozaki M; Masubuchi Y; Horie T
    In Vivo; 2002; 16(1):61-5. PubMed ID: 11980363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggravation of acute galactosamine hepatitis by a sodic bicarbonated water in rats (author's transl)].
    de La Tour J; Souchard M; Chariot J; Rozé C; Potet F; Vaille C
    J Pharmacol; 1981; 12(1):37-50. PubMed ID: 6261045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol.
    Kitajima S; Ogawa N; Ariyoshi T
    Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):14-20. PubMed ID: 7953190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pulsed magnetic fields on triglyceride and cholesterol levels in plasma of rats.
    Bellossi A; Pouvreau-Quilien V; Rocher C; Ruelloux M
    Panminerva Med; 1998 Dec; 40(4):276-9. PubMed ID: 9973821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged oval cell proliferation with Ito cell activation and extracellular matrix accumulation in galactosamine-induced acute hepatitis in mini rats.
    Uetsuka K; Suzuki M; Nakayama H; Doi K
    Histol Histopathol; 1997 Oct; 12(4):937-43. PubMed ID: 9302554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular analysis of alpha-fetoprotein gene activation during carbon tetrachloride and D-galactosamine-induced acute liver injury in rats.
    Tournier I; Legrès L; Schoevaert D; Feldmann G; Bernuau D
    Lab Invest; 1988 Nov; 59(5):657-65. PubMed ID: 2460696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
    Nagakawa J; Hirota K; Hishinuma I; Miyamoto K; Sonoda J; Yamanaka T; Katayama K; Yamatsu I
    J Pharmacol Exp Ther; 1993 Jan; 264(1):496-500. PubMed ID: 8423547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thiamine diphosphate pool and its biosynthesis in the liver in galactosamine hepatitis].
    Trebukhina RV; Moiseenok AG; Petushok VG; Tumanov VN; Gorenshteĭn BI; Sheĭbak VM; Omel'ianchik SN
    Ukr Biokhim Zh (1978); 1989; 61(4):73-7. PubMed ID: 2588337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.
    Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yasuda M; Yamanaka T; Katayama K
    Immunopharmacol Immunotoxicol; 1991; 13(4):485-98. PubMed ID: 1774433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
    Mach T
    Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenotransplantation of human umbilical cord blood mononuclear cells to rats with D-galactosamine-induced hepatitis.
    Alvarez-Mercado AI; Sáez-Lara MJ; García-Mediavilla MV; Sánchez-Campos S; Abadía F; Cabello-Donayre M; Gil A; González-Gallego J; Fontana L
    Cell Transplant; 2008; 17(7):845-57. PubMed ID: 19044210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in endogenous prostaglandin levels during D-galactosamine-induced liver injury.
    Koyama Y; Imoto M; Tanaka M; Fukuda Y; Satake T; Ozawa T
    Biochem Int; 1989 Aug; 19(2):421-8. PubMed ID: 2818605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxic effect of D-galactosamine and protective role of lipid emulsion.
    Ferencíková R; Cervinková Z; Drahota Z
    Physiol Res; 2003; 52(1):73-8. PubMed ID: 12625810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatoprotective effect of several constituents of Lonicera fulvotomentosa hsu et S. C. cheng, and L. macranthoide Hand.-Mazz. on CC1(4) and D-galactosamine induced liver injuries in mice and rats].
    Shi J; Chen X; Wan L
    Zhongguo Zhong Yao Za Zhi; 1999 Jun; 24(6):363-4, 384. PubMed ID: 12212032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat.
    James GW; Pickering RW
    Arzneimittelforschung; 1976; 26(12):2197-9. PubMed ID: 1037274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.